Table 3 Sarcoma advisory group guidelines for osteosarcoma
Category | 1st line | 2nd line | 3rd line and other |
|---|---|---|---|
Resectable <30 years | Doxorubicin, cisplatin methotrexate ± mifamurtide [101] | Ifosfamide and etoposide [102] | Gemcitabine and docetaxel [103] or oral etoposide |
Other | Doxorubicin, cisplatin ± methotrexate [101] | Ifosfamide, etoposide ± methotrexate | Gemcitabine and docetaxel [103] or oral etoposide |